Medicare Drug Price Negotiation Program
The next batch of drugs under negotiations
The Centers for Medicare and Medicaid Services (CMS) issued a draft guidance on May 12th for the third round of Medicare drug negotiations. The government has until the end of November to announce the agreed-upon Medicare prices, with the lower…
Operationalizing the scope of the Medicare drug negotiations
The Inflation Reduction Act of 2022 allowed Medicare to directly negotiate the prices of certain high-expenditure, single-source drugs without generic or biosimilar competition. The first set of negotiated prices will take effect in 2026. The Centers for Medicare and Medicaid…
The Inflation Reduction Act’s Medicare Drug Price Negotiation Program updated
The Inflation Reduction Act of 2022 included several provisions to lower Medicare drug costs by requiring the Secretary of Health and Human Services (HHS) to negotiate prices with drug companies for certain drugs covered under Medicare Part D. Juliette Cubanski…